Applied Capital LLC’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.5M Buy
6,783
+409
+6% +$113K 0.61% 42
2026
Q1
$1.88M Buy
6,374
+62
+1% +$18.4K 0.89% 25
2025
Q4
$1.72M Buy
6,312
+272
+5% +$73.9K 1.02% 31
2025
Q3
$1.63M Buy
6,040
+48
+0.8% +$13.1K 1.01% 35
2025
Q2
$1.65M Buy
5,992
+45
+0.8% +$12.2K 1.2% 31
2025
Q1
$1.58M Buy
5,947
+165
+3% +$40.7K 1.24% 31
2024
Q4
$1.34M Sell
5,782
-34
-0.6% -$7.82K 1.04% 39
2024
Q3
$1.28M Sell
5,816
-16
-0.3% -$3.31K 1% 46
2024
Q2
$1.15M Buy
5,832
+283
+5% +$58.5K 1% 44
2024
Q1
$1.19M Buy
5,549
+28
+0.5% +$5.88K 0.97% 44
2023
Q4
$1.13M Hold
5,521
1.04% 42
2023
Q3
$1.02M Buy
5,521
+8
+0.1% +$1.59K 1.01% 43
2023
Q2
$1.02M Buy
5,513
+262
+5% +$48.4K 0.97% 43
2023
Q1
$1.01M Buy
5,251
+663
+14% +$120K 1% 44
2022
Q4
$772K Buy
+4,588
New +$797K 0.76% 54

Other funds holding CME

Applied Capital LLC's CME Position: Q2 2026 in Review

Applied Capital LLC increased its CME Group (CME) stake by 6.4% in Q2 2026, buying an estimated $113K and bringing the position to 6,783 shares worth $1.5M. The position accounts for 0.61% of the portfolio, ranked #42.

Applied Capital LLC first reported a position in CME in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.88M in Q1 2026. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Applied Capital LLC held 6,783 shares of CME Group worth $1.5M as of Q2 2026.
  • Applied Capital LLC bought 409 CME Group shares in Q2 2026, an estimated $113K.
  • CME Group made up 0.61% of Applied Capital LLC's portfolio in Q2 2026, its #42 holding.
  • Applied Capital LLC first reported a position in CME Group in Q4 2022 and has held it in 15 quarters since.
  • Applied Capital LLC's CME Group position peaked at $1.88M in Q1 2026.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Applied Capital LLC's 13F filing for Q2 2026, filed 15 Jul 2026.